New gene therapy offers hope for Tough-to-Treat bladder cancer
Disease control
Recruiting now
This study is testing a new gene therapy called EG-70 for people with non-muscle invasive bladder cancer who haven't responded well to standard BCG treatment or are ineligible for it. The therapy is delivered directly into the bladder to stimulate the immune system to fight cance…
Phase: PHASE1, PHASE2 • Sponsor: enGene, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC